Jinan Kangzhong Pharmaceutical Technology Development

Jinan Kangzhong Pharmaceutical Technology Development (now operating as Shandong Kangzhonghong) is a prominent pharmaceutical research and development enterprise based in Jinan, China. Founded in 2001, the company specializes in the discovery and development of innovative chemical drugs, high-end generics, and the secondary development of traditional Chinese medicines. It is widely recognized for being the first company in China to develop and transfer the technology for Montmorillonite (Smecta generic), a major gastrointestinal treatment, capturing a significant portion of the domestic market. The company's proprietary pipeline includes several clinical-stage programs for allergic rhinitis, cough, and colitis, and it has been supported by China's National Major New Drug Discovery projects. Kangzhong operates as both a drug developer and a technology transfer partner for major Chinese pharmaceutical groups.